Matthew Di Guglielmo to Child
This is a "connection" page, showing publications Matthew Di Guglielmo has written about Child.
Connection Strength
0.463
-
Di Guglielmo MD, Holbrook J, Stabley D, Robbins KM, Boyce B, Hardy H, Adeyemi A. The Intestinal Tract Brush Border in Young Children Uniformly Expresses Guanylate Cyclase C. Appl Immunohistochem Mol Morphol. 2023 03 01; 31(3):154-162.
Score: 0.101
-
Rohde JF, Goyal NK, Slovin SR, Hossain J, Pachter LM, Di Guglielmo MD. Association of Positional Plagiocephaly and Developmental Delay Within a Primary Care Network. J Dev Behav Pediatr. 2021 Feb-Mar 01; 42(2):128-134.
Score: 0.088
-
Di Guglielmo MD, Perdue L, Adeyemi A, van Golen KL, Corao DU. Immunohistochemical Staining for Uroguanylin, a Satiety Hormone, is Decreased in Intestinal Tissue Specimens From Female Adolescents With Obesity. Pediatr Dev Pathol. 2018 May-Jun; 21(3):285-295.
Score: 0.069
-
Di Guglielmo MD, Greenspan JS, Abatemarco DJ. Pediatrician preferences, local resources, and economic factors influence referral to a subspecialty access clinic. Prim Health Care Res Dev. 2016 11; 17(6):628-635.
Score: 0.063
-
Di Guglielmo MD, Plesnick J, Greenspan JS, Sharif I. A new model to decrease time-to-appointment wait for gastroenterology evaluation. Pediatrics. 2013 May; 131(5):e1632-8.
Score: 0.051
-
Di Guglielmo MD, Hertzog JH. Aortic pseudoaneurysm in a child with a left mainstem bronchial stent. Pediatr Crit Care Med. 2008 Jul; 9(4):e31-4.
Score: 0.037
-
Babu Balagopal P, Kohli R, Uppal V, Averill L, Shah C, McGoogan K, Di Guglielmo M, Goran M, Hossain MJ. Effect of N-acetyl cysteine in children with metabolic dysfunction-associated steatotic liver disease-A pilot study. J Pediatr Gastroenterol Nutr. 2024 Sep; 79(3):652-660.
Score: 0.028
-
Ricciuto A, Liu K, El-Matary W, Amin M, Amir AZ, Aumar M, Auth M, Di Guglielmo MD, Druve Tavares Fagundes E, Rodrigues Ferreira A, Furuya KN, Gupta N, Guthery S, Horslen SP, Jensen K, Kamath BM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Mack C, Martinez M, Montano-Loza A, Ovchinsky N, Papadopoulou A, Perito ER, Sathya P, Schwarz KB, Shah U, Shteyer E, Soufi N, Stevens JP, Taylor A, Tessier ME, Valentino P, Woynarowski M, Deneau M. Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium. Aliment Pharmacol Ther. 2024 05; 59(10):1236-1247.
Score: 0.027